Fintel on MSN
Morgan Stanley maintains Bristol-Myers Squibb Company - preferred security (BMYMP) underweight recommendation
Fintel reports that on December 12, 2025, Morgan Stanley maintained coverage of Bristol-Myers Squibb Company - Preferred Security (OTCPK:BMYMP) with a Underweight recommendation. Analyst Price ...
I share Q3 updates on many of my top holdings, and why I still think REITs are a better bet over tech. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback